Medikabazaar aims for ₹3,000 crore revenue in FY26
Medikabazaar, the B2B medical supply startup, is turning around after heavy losses last year and now aims for ₹3,000 crore revenue in FY26.
After a loss of nearly ₹150 crore in FY25, new leadership under CEO Dinesh Lodha has initiated a turnaround with tighter controls and fresh strategies.
New leadership under CEO Dinesh Lodha is driving the change
The company rolled out new business lines like MB+ for medical consumables and diagnostics—hoping to hit ₹100 crore in recurring revenue by March 2026 (as per current fiscal targets).
Medikabazaar is also growing its reach to smaller city hospitals with transparent pricing and no middlemen.
On top of that, it's looking abroad: exports are set to jump from 5-6% of business now to as much as 20%, especially targeting the Middle East and Africa.
All this comes after a major audit revealed past revenue issues—prompting stricter governance so history doesn't repeat itself.